‘Orphan’ drugs boon for ASX stocks, patients
‘Orphan’ drug status is offering these ASX pharma stocks a chance to turn a healthy profit – and give hope to those suffering rare conditions. Rare or “orphan” diseases affect a small number of people globally, defined as less than 200,000 in the US and 10,000 in Australia. Normally these conditions would be uneconomical to … [Read more…]